Hepatic Function and Liver Enzyme Markers
Hepatic function and liver enzyme markers are the panel of serum analytes — most commonly the aminotransferases (ALT, AST), alkaline phosphatase, gamma-glutamyl transferase, bilirubin, and albumin — used to detect, characterise, and monitor liver injury and dysfunction. Conventionally grouped as liver function tests, these markers do not measure a single function but rather report a mixture of hepatocellular leakage, cholestatic enzyme induction, pigment clearance, and synthetic capacity.
Definition
Liver function tests are a group of serum biochemical measurements — aminotransferases, alkaline phosphatase, gamma-glutamyl transferase, bilirubin, and albumin among others — used together to screen for, classify, and follow disorders of the liver and biliary tract.
Scope
This area orients the reader to the biochemical panel as a whole: what each marker reflects, how the markers are conventionally read as patterns (hepatocellular versus cholestatic), and the conceptual limits of calling them tests of function. It links to the detailed topic entries for the individual analytes. It treats the panel as a clinical-biochemistry reference subject and is not a guide to interpreting any individual's results.
Sub-topics
Core questions
- What does each marker in the panel actually reflect at the tissue and molecular level?
- How are the markers read together to distinguish hepatocellular from cholestatic patterns?
- Why are these markers of injury and clearance, and which markers (albumin, coagulation) actually reflect synthetic function?
- What are the limits of sensitivity and specificity of the panel for detecting liver disease?
Key concepts
- Hepatocellular versus cholestatic injury pattern
- Markers of injury (enzyme leakage) versus markers of function (synthesis, clearance)
- Aminotransferases (ALT, AST) as cytosolic and mitochondrial leakage enzymes
- Cholestatic markers (alkaline phosphatase, gamma-glutamyl transferase)
- Bilirubin as a measure of pigment clearance
- Albumin and prothrombin time as indices of synthetic capacity
- Reference intervals and the R-ratio for pattern classification
Mechanisms
The panel mixes markers of fundamentally different origin. Aminotransferases are intracellular enzymes that leak into serum when hepatocyte membranes are damaged, so their rise signals hepatocellular injury rather than loss of function. Alkaline phosphatase and gamma-glutamyl transferase are induced and released in cholestasis, when bile flow is impaired. Bilirubin reflects the liver's capacity to take up, conjugate, and excrete the pigment derived from heme catabolism. Albumin and clotting factors, synthesised by the hepatocyte, are the markers that genuinely report synthetic function, and they fall only when a large fraction of hepatic reserve is lost. Reading these markers together as patterns — predominantly raised aminotransferases versus predominantly raised alkaline phosphatase — is the conceptual basis of the panel.
Clinical relevance
The liver enzyme panel is among the most frequently ordered sets of laboratory tests, and understanding what each marker reflects is foundational to clinical biochemistry. This area describes the biochemical meaning and conventional grouping of the markers; it explains how the panel is generated and interpreted at the level of patterns and is not a basis for diagnosing or treating any individual.
Epidemiology
Abnormal liver chemistries are common in the general population, frequently detected incidentally in asymptomatic people, and their prevalence has risen alongside metabolic dysfunction-associated fatty liver disease; the appropriate evaluation of such incidental abnormalities is the subject of dedicated clinical guidance.
Evidence & guidelines
Major professional guidance, including the American College of Gastroenterology clinical guideline on the evaluation of abnormal liver chemistries, frames how the panel should be interpreted and worked up, while narrative reviews and standard clinical-chemistry textbooks describe the biochemistry of each marker.
History
The use of serum enzymes to detect liver injury developed through the mid-twentieth century as the aminotransferases and alkaline phosphatase were characterised and standardised for clinical use; the conventional label liver function tests has persisted even though most markers in the panel measure injury or clearance rather than function, a recognised misnomer in clinical chemistry.
Debates
- Are liver function tests misnamed?
- Most markers in the conventional panel (aminotransferases, alkaline phosphatase, bilirubin) reflect injury or impaired clearance rather than hepatic synthetic function; commentators note that only albumin and coagulation indices truly measure function, and the term liver chemistries is often preferred.
Related topics
Seminal works
- pratt-kaplan-2000
- kwo-2017
Frequently asked questions
- Do liver function tests actually measure liver function?
- Mostly no. The aminotransferases, alkaline phosphatase, and bilirubin reflect hepatocellular injury, cholestasis, or impaired pigment clearance; only albumin and coagulation factors genuinely reflect the liver's synthetic function.
- What distinguishes a hepatocellular from a cholestatic pattern?
- A hepatocellular pattern is dominated by raised aminotransferases (ALT, AST), whereas a cholestatic pattern is dominated by raised alkaline phosphatase and gamma-glutamyl transferase; the relative elevation is used to classify the pattern.